Glioblastoma Multiforme Treatment Market Size, Share & Trends Report

Glioblastoma Multiforme Treatment Market Size, Share & Trends Analysis Report By Treatment (Radiation Therapy, Immunotherapy), By Drug Class, By End Use, By Region, And Segment Forecasts, 2021 - 2028

  • Report ID: GVR-4-68039-527-3
  • Number of Pages: 110
  • Format: Electronic (PDF)
  • Historical Range: 2017 - 2019
  • Industry: Healthcare

Market Segmentation

  • Glioblastoma Multiforme (GBM) Treatment Outlook (Revenue, USD Million, 2017 - 2028)
    • Surgery
    • Radiation therapy
    • Chemotherapy
    • Targeted Therapy
    • Tumor Treating Field (TTF) Therapy
    • Immunotherapy
  • Glioblastoma Multiforme (GBM) Treatment Drug Class Outlook (Revenue, USD Million, 2017 - 2028)
    • Temozolomide
    • Bevacizumab
    • Lomustine
    • Carmustine Wafers
    • Others
  • Glioblastoma Multiforme (GBM) Treatment End-use Outlook (Revenue, USD Million, 2017 - 2028)
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
  • Glioblastoma Multiforme (GBM) Treatment Regional Outlook (Revenue, USD Million, 2017 - 2028)
    • North America
      • North America GBM Treatment Market, By Treatment
        • Surgery
        • Radiation therapy
        • Chemotherapy
        • Targeted Therapy
        • Tumor Treating Field (TTF) Therapy
        • Immunotherapy
      • North America GBM Treatment Market, By Drug Class
        • Temozolomide
        • Bevacizumab
        • Lomustine
        • Carmustine wafers
        • Others
      • North America GBM Treatment Market, By End Use
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
      • U.S.
        • U.S. GBM Treatment Market, By Treatment
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • U.S. GBM Treatment Market, By Drug Class
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine wafers
          • Others
        • U.S. GBM Treatment Market, By End Use
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • Canada
        • Canada GBM Treatment Market, By Treatment
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Canada GBM Treatment Market, By Drug Class
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine wafers
          • Others
        • Canada GBM Treatment Market, By End Use
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
    • Europe
      • Europe GBM Treatment Market, By Treatment
        • Surgery
        • Radiation therapy
        • Chemotherapy
        • Targeted Therapy
        • Tumor Treating Field (TTF) Therapy
        • Immunotherapy
      • Europe GBM Treatment Market, By Drug Class
        • Temozolomide
        • Bevacizumab
        • Lomustine
        • Carmustine wafers
        • Others
      • Europe GBM Treatment Market, By End Use
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
      • U.K.
        • U.K. GBM Treatment Market, By Treatment
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • U.K. GBM Treatment Market, By Drug Class
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine wafers
          • Others
        • U.K. GBM Treatment Market, By End Use
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • Germany
        • Germany GBM Treatment Market, By Treatment
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Germany GBM Treatment Market, By Drug Class
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine wafers
          • Others
        • Germany GBM Treatment Market, By End Use
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • France
        • France GBM Treatment Market, By Treatment
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • France GBM Treatment Market, By Drug Class
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine wafers
          • Others
        • France GBM Treatment Market, By End Use
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • Italy
        • Italy GBM Treatment Market, By Treatment
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Italy GBM Treatment Market, By Drug Class
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine wafers
          • Others
        • Italy GBM Treatment Market, By End Use
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • Spain
        • Spain GBM Treatment Market, By Treatment
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Spain GBM Treatment Market, By Drug Class
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine wafers
          • Others
        • Spain GBM Treatment Market, By End Use
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • Russia
        • Russia GBM Treatment Market, By Treatment
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Russia GBM Treatment Market, By Drug Class
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine wafers
          • Others
        • Russia GBM Treatment Market, By End Use
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
    • Asia Pacific
      • Asia Pacific GBM Treatment Market, By Treatment
        • Surgery
        • Radiation therapy
        • Chemotherapy
        • Targeted Therapy
        • Tumor Treating Field (TTF) Therapy
        • Immunotherapy
      • Asia Pacific GBM Treatment Market, By Drug Class
        • Temozolomide
        • Bevacizumab
        • Lomustine
        • Carmustine wafers
        • Others
      • Asia Pacific GBM Treatment Market, By End Use
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
      • Japan
        • Japan GBM Treatment Market, By Treatment
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Japan GBM Treatment Market, By Drug Class
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine wafers
          • Others
        • Japan GBM Treatment Market, By End Use
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • China
        • China GBM Treatment Market, By Treatment
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • China GBM Treatment Market, By Drug Class
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine wafers
          • Others
        • China GBM Treatment Market, By End Use
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • India
        • India GBM Treatment Market, By Treatment
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • India GBM Treatment Market, By Drug Class
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine wafers
          • Others
        • India GBM Treatment Market, By End Use
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • South Korea
        • South Korea GBM Treatment Market, By Treatment
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • South Korea GBM Treatment Market, By Drug Class
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine wafers
          • Others
        • South Korea GBM Treatment Market, By End Use
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • Australia
        • Australia GBM Treatment Market, By Treatment
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Australia GBM Treatment Market, By Drug Class
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine wafers
          • Others
        • Australia GBM Treatment Market, By End Use
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • Singapore
        • Singapore GBM Treatment Market, By Treatment
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Singapore GBM Treatment Market, By Drug Class
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine wafers
          • Others
        • Singapore GBM Treatment Market, By End Use
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
    • Latin America
      • Latin America GBM Treatment Market, By Treatment
        • Surgery
        • Radiation therapy
        • Chemotherapy
        • Targeted Therapy
        • Tumor Treating Field (TTF) Therapy
        • Immunotherapy
      • Latin America GBM Treatment Market, By Drug Class
        • Temozolomide
        • Bevacizumab
        • Lomustine
        • Carmustine wafers
        • Others
      • Latin America GBM Treatment Market, By End Use
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
      • Brazil
        • Brazil GBM Treatment Market, By Treatment
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Brazil GBM Treatment Market, By Drug Class
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine wafers
          • Others
        • Brazil GBM Treatment Market, By End Use
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • Mexico
        • Mexico GBM Treatment Market, By Treatment
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Mexico GBM Treatment Market, By Drug Class
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine wafers
          • Others
        • Mexico GBM Treatment Market, By End Use
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • Argentina
        • Argentina GBM Treatment Market, By Treatment
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Argentina GBM Treatment Market, By Drug Class
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine wafers
          • Others
        • Argentina GBM Treatment Market, By End Use
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
    • Middle East & Africa
      • Middle East & Africa GBM Treatment Market, By Treatment
        • Surgery
        • Radiation therapy
        • Chemotherapy
        • Targeted Therapy
        • Tumor Treating Field (TTF) Therapy
        • Immunotherapy
      • Middle East & Africa GBM Treatment Market, By Drug Class
        • Temozolomide
        • Bevacizumab
        • Lomustine
        • Carmustine wafers
        • Others
      • Middle East & Africa GBM Treatment Market, By End Use
        • Hospitals
        • Clinics
        • Ambulatory Surgical Centers
      • South Africa
        • South Africa GBM Treatment Market, By Treatment
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • South Africa GBM Treatment Market, By Drug Class
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine wafers
          • Others
        • South Africa GBM Treatment Market, By End Use
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • Saudi Arabia
        • Saudi Arabia GBM Treatment Market, By Treatment
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • Saudi Arabia GBM Treatment Market, By Drug Class
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine wafers
          • Others
        • Saudi Arabia GBM Treatment Market, By End Use
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers
      • UAE
        • UAE GBM Treatment Market, By Treatment
          • Surgery
          • Radiation therapy
          • Chemotherapy
          • Targeted Therapy
          • Tumor Treating Field (TTF) Therapy
          • Immunotherapy
        • UAE GBM Treatment Market, By Drug Class
          • Temozolomide
          • Bevacizumab
          • Lomustine
          • Carmustine wafers
          • Others
        • UAE GBM Treatment Market, By End Use
          • Hospitals
          • Clinics
          • Ambulatory Surgical Centers

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2017 to 2028
  • Market estimates and forecast for product segments up to 2028
  • Regional market size and forecast for product segments up to 2028
  • Market estimates and forecast for application segments up to 2028
  • Regional market size and forecast for application segments up to 2028
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.